These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7533224)

  • 1. Twenty-four-hour blood pressure profiles in patients with mild-to-moderate hypertension: moxonidine versus captopril.
    Kraft K; Vetter H
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S29-33. PubMed ID: 7533224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Moxonidine vs. captopril in minor to intermediate hypertension. Double-blind study of effectiveness and tolerance].
    Lotti G; Gianrossi R
    Fortschr Med; 1993 Sep; 111(27):429-32. PubMed ID: 8225149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation by 24-hour ambulatory blood pressure monitoring of efficacy of benazepril 20 mg plus hydrochlorothiazide 25 mg fixed combination as compared to captopril 50 mg [corrected] plus hydrochlorothiazide 25 mg fixed combination in treating mild to moderate hypertension: a double-blind, within-patient, placebo-controlled study.
    Fogari R; Zoppi A; Tettamanti F; Tettamanzi D; Lusardi P; Motolese M
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):687-93. PubMed ID: 7869731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements.
    Hempel G; Karlsson MO; de Alwis DP; Toublanc N; McNay J; Schaefer HG
    Clin Pharmacol Ther; 1998 Dec; 64(6):622-35. PubMed ID: 9871427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of manual versus ambulatory blood pressure measurements with pharmacokinetic-pharmacodynamic modeling of antihypertensive compounds: application to moxonidine.
    Trocóniz IF; de Alwis DP; Tillmann C; Callies S; Mitchell M; Schaefer HG
    Clin Pharmacol Ther; 2000 Jul; 68(1):18-27. PubMed ID: 10945312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension.
    Roca-Cusachs A; Oigman W; Lepe L; Cifkova R; Karpov YA; Harron DW
    Acta Cardiol; 1997; 52(6):495-506. PubMed ID: 9542575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxonidine and hydrochlorothiazide in combination: a synergistic antihypertensive effect.
    Frei M; Küster L; Gardosch von Krosigk PP; Koch HF; Küppers H
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S25-8. PubMed ID: 7533223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of moxonidine and clonidine HCl in treating patients with hypertension.
    Plänitz V
    J Clin Pharmacol; 1987 Jan; 27(1):46-51. PubMed ID: 3316304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild to moderate essential hypertension.
    Prichard BN; Jäger BA; Luszick JH; Küster LJ; Verboom CN; Hughes PR; Sauermann W; Küppers HE
    Blood Press; 2002; 11(3):166-72. PubMed ID: 12126263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive efficacy and safe use of once-daily sustained-release diltiazem in the elderly: a comparison with captopril. The Dilcacomp Study Group.
    Nicaise J; Neveux E; Blondin P
    J Int Med Res; 1995; 23(4):244-53. PubMed ID: 7589767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension.
    Kemme MJ; vd Post JP; Schoemaker RC; Straub M; Cohen AF; van Gerven JM
    Br J Clin Pharmacol; 2003 Jun; 55(6):518-25. PubMed ID: 12814444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MARRIAGE: A Randomized Trial of Moxonidine
    Valensi P; Jambart S
    J Cardiovasc Pharmacol Ther; 2024; 29():10742484241258381. PubMed ID: 38828542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxonidine improves insulin sensitivity in insulin-resistant hypertensives.
    Haenni A; Lithell H
    J Hypertens Suppl; 1999 Aug; 17(3):S29-35. PubMed ID: 10489096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness and tolerance of benazepril versus captopril in patients with hypertension].
    Ol'binskaia LI; Golubev SA; Morozova TE
    Klin Med (Mosk); 1995; 73(5):36-8. PubMed ID: 8815273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of amlodipine and captopril in hypertension based on 24-hour ambulatory monitoring.
    Lacourcière Y; Poirier L; Provencher P
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S20-3. PubMed ID: 7522283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, parallel, comparative evaluation of amlodipine vs. captopril in the monotherapeutic treatment of mild and moderate essential hypertension.
    Velasco M; Urbina A; Silva H; Fonseca R; Guevara J; Hernandez R; Pieretti OH
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S19-21. PubMed ID: 16296701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
    Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy.
    Machnig T; Henneke KH; Engels G; Pongratz G; Schmalzl M; Gellert J; Bachmann K
    Cardiology; 1994; 85(2):101-10. PubMed ID: 7954561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the evenness of the antihypertensive effect of losartan and captopril by using a 24-hour monitoring of arterial pressure].
    Gorbunov VM; Savina LV; Metelitsa VI; Deev AD
    Ter Arkh; 2001; 73(2):38-43. PubMed ID: 11338852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.